Racial Differences in Survival and Healthcare Resource Utilization Among Medicaid-Insured Adults With Metastatic Prostate Cancer
White and BAA Medicaid-insured patients with mCSPC and mCRPC had similar survival outcomes, whereas Hispanic patients, an under-studied minority group, had significantly longer survival compared to White patients. Differential HRU was observed among racial groups to different extents in the mCSPC and mCRPC cohorts. Further studies are needed to understand the relation between racial disparities in HRU and OS.
Authors
- Bhakti Arondekar (ORCID: https://orcid.org/0000-0002-4553-0094)
- Jasmina Ivanova (ORCID: https://orcid.org/0000-0002-4028-9676)
- Tracy Guo
- Alexander Niyazov (ORCID: https://orcid.org/0000-0003-1292-9661)
- Stephen J. Freedland (ORCID: https://orcid.org/0000-0002-8104-6419)
- Maral DerSarkissian (ORCID: https://orcid.org/0000-0002-5528-6531)
- Enrico Zanardo (ORCID: https://orcid.org/0009-0009-7011-1180)
- Mei Sheng Duh (ORCID: https://orcid.org/0000-0001-5035-6687)
- Deepshekhar Gupta (ORCID: https://orcid.org/0000-0002-3695-3546)
- Jingru Wang (ORCID: https://orcid.org/0009-0006-8683-1121)
Institutions
- Cedars-Sinai Medical Center (US)
- Pfizer (United States) (US)
- Menlo School (US)
- Durham VA Medical Center (US)
- Flatiron Health (United States) (US)
- Analysis Group (United States) (US)
Publication Details
- Journal
- Clinical Genitourinary Cancer
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1016/j.clgc.2024.102291
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer